Contribution: Industrial Research Assistance Program – Contributions to Firms
Axem Neurotechnology Inc.
$400,000.00
Axem Home System Completion for Pivotal Clinical Trials
FY 2022-23 · 2022-06-01
Summary
Axem Neurotechnology is preparing to conduct pivotal clinical trials in 2023; this project entails work necessary for the use of those data for regulatory clearance (i.e., generating production equivalent version of the Axem Home headband), as well as work to de-risk those clinical trials with respect to their study endpoints, as well as with respect to the role of those data in procuring subsequent investment.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Dartmouth|Dartmouth, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
761868496
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 400,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 400 000 dollars.
Agreement End Date
2023-03-31
Agreement Number
992488
Agreement Start Date
2022-06-01
Agreement Title
Axem Home System Completion for Pivotal Clinical Trials
Agreement Title (French)
Achèvement du système Axem Home pour les essais cliniques clés
Agreement Type
Contribution
Agreement Value
$400,000.00
Amendment Date
2022-09-29
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Axem Neurotechnology is preparing to conduct pivotal clinical trials in 2023; this project entails work necessary for the use of those data for regulatory clearance (i.e., generating production equivalent version of the Axem Home headband), as well as work to de-risk those clinical trials with respect to their study endpoints, as well as with respect to the role of those data in procuring subsequent investment.
Description (French)
Axem Neurotechnology se prépare à mener des essais cliniques clés en 2023; ce projet comprend les travaux nécessaires à l'utilisation de ces données pour l'autorisation réglementaire (c.-à-d. la production d'une version équivalente du bandeau d'Axem Home), ainsi que les travaux visant à réduire le risque de ces essais cliniques en ce qui concerne les résultats de l'étude, ainsi que le rôle de ces données dans l'obtention d'investissements ultérieurs.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Dartmouth--Cole Harbour
Federal Riding (French)
Dartmouth--Cole Harbour
Federal Riding Number
12004
NAICS Code
541514
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
761868496
Recipient City
Dartmouth|Dartmouth
Recipient Country
CA
Recipient Legal Name
Axem Neurotechnology Inc.
Recipient Postal Code
B3B 1V7
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2022-2023-Q2-992488
